NCT06483997Active, not recruiting
Diet, Hepcidin, and Chemotherapy RDI
Associations Between Diet, Hepcidin, and Relative Dose Intensity Among Women Receiving Chemotherapy for Breast or Gynecological Cancer
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
This prospective, observational cohort study will evaluate the extent of associations between self-reported pro- or anti- inflammatory dietary intake patterns for one month before induction chemotherapy for gynecological cancer or neo/adjuvant chemotherapy for breast cancer and baseline serum hepcidin concentrations. Associations between hepcidin concentration and relative dose intensity (RDI) of chemotherapy will also be evaluated.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 24 Jun 2024
- Start date
- 16 Aug 2024
- Primary completion date
- Jul 2027
- Lead sponsor
- George Washington University
- Diseases
- Endometrial cancer, Ovarian cancer
- NCT number
- NCT06483997
What you commit to
- Study type: Observational
- Planned participants: 100
- From 16 Aug 2024 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receipt of erythropoietin-stimulating agents or blood transfusion in the 6 weeks prior to initial testing
- Women who are cognitively unable to provide a diet history for the month prior to assessment.
Lab values
- Prior primary hematological condition that would cause abnormal blood counts (e.g. leukemia)
Other
- Pregnant at the time of potential enrollment
Who the study is looking for
- Have been diagnosed with invasive breast cancer, OR
- Have been diagnosed with epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, OR
- Have been diagnosed with endometrial cancer
- Are chemotherapy-naïve
- Are scheduled to receive neoadjuvant chemotherapy (or adjuvant chemotherapy following lumpectomy for breast cancer patients) or neoadjuvant/induction chemotherapy for gynecological cancer at GW Cancer Center
Age in the registry: 21 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| George Washington University Cancer Center Coordinator of this site? Confirm its status | Washington D.C. | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.